Ameriprise’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.5M Sell
109,693
-17,338
-14% -$1.97M ﹤0.01% 1649
2025
Q1
$13.4M Buy
127,031
+31,327
+33% +$3.29M ﹤0.01% 1562
2024
Q4
$10.3M Buy
95,704
+1,759
+2% +$188K ﹤0.01% 1780
2024
Q3
$9.4M Sell
93,945
-6,096
-6% -$610K ﹤0.01% 1845
2024
Q2
$8.43M Sell
100,041
-16,252
-14% -$1.37M ﹤0.01% 1902
2024
Q1
$8.5M Buy
116,293
+9,718
+9% +$710K ﹤0.01% 1932
2023
Q4
$7.61M Sell
106,575
-28,868
-21% -$2.06M ﹤0.01% 2016
2023
Q3
$8.12M Sell
135,443
-10,651
-7% -$638K ﹤0.01% 1870
2023
Q2
$10.5M Buy
146,094
+13,566
+10% +$978K ﹤0.01% 1733
2023
Q1
$9.75M Sell
132,528
-2,549
-2% -$188K ﹤0.01% 1796
2022
Q4
$9.02M Sell
135,077
-95,776
-41% -$6.4M ﹤0.01% 1822
2022
Q3
$12.4M Sell
230,853
-9,809
-4% -$527K ﹤0.01% 1497
2022
Q2
$13.4M Buy
240,662
+62,171
+35% +$3.46M ﹤0.01% 1502
2022
Q1
$12.5M Sell
178,491
-1,125
-0.6% -$78.9K ﹤0.01% 1721
2021
Q4
$17.3M Buy
179,616
+2,122
+1% +$204K ﹤0.01% 1533
2021
Q3
$15.4M Buy
177,494
+31,403
+21% +$2.73M ﹤0.01% 1483
2021
Q2
$12M Sell
146,091
-1,638
-1% -$134K ﹤0.01% 1789
2021
Q1
$14.1M Sell
147,729
-121,846
-45% -$11.6M ﹤0.01% 1594
2020
Q4
$16.7M Sell
269,575
-61,210
-19% -$3.8M 0.01% 1356
2020
Q3
$19.7M Sell
330,785
-401,186
-55% -$23.9M 0.01% 1082
2020
Q2
$51.1M Buy
731,971
+200,799
+38% +$14M 0.02% 620
2020
Q1
$24.1M Buy
531,172
+37,393
+8% +$1.7M 0.01% 840
2019
Q4
$32.1M Sell
493,779
-38,372
-7% -$2.5M 0.01% 904
2019
Q3
$33M Buy
532,151
+31,465
+6% +$1.95M 0.01% 847
2019
Q2
$35.6M Sell
500,686
-29,330
-6% -$2.09M 0.02% 836
2019
Q1
$41.6M Sell
530,016
-569,639
-52% -$44.7M 0.02% 737
2018
Q4
$93.1M Buy
1,099,655
+66,823
+6% +$5.66M 0.05% 396
2018
Q3
$177M Sell
1,032,832
-193,734
-16% -$33.2M 0.06% 307
2018
Q2
$159M Sell
1,226,566
-11,742
-0.9% -$1.52M 0.07% 282
2018
Q1
$128M Buy
1,238,308
+585,291
+90% +$60.3M 0.06% 317
2017
Q4
$55.8M Buy
653,017
+37,595
+6% +$3.21M 0.03% 547
2017
Q3
$52.3M Buy
615,422
+47,481
+8% +$4.03M 0.02% 555
2017
Q2
$43M Sell
567,941
-4,122
-0.7% -$312K 0.02% 612
2017
Q1
$37.8M Sell
572,063
-97,936
-15% -$6.47M 0.02% 656
2016
Q4
$42.5M Sell
669,999
-21,663
-3% -$1.37M 0.02% 589
2016
Q3
$44M Buy
691,662
+39,675
+6% +$2.53M 0.02% 549
2016
Q2
$48.4M Buy
651,987
+27,896
+4% +$2.07M 0.03% 489
2016
Q1
$41.7M Buy
624,091
+104,743
+20% +$7M 0.02% 545
2015
Q4
$35.1M Buy
519,348
+4,359
+0.8% +$295K 0.02% 614
2015
Q3
$27.5M Sell
514,989
-42,727
-8% -$2.28M 0.02% 735
2015
Q2
$35.1M Buy
557,716
+24,779
+5% +$1.56M 0.02% 668
2015
Q1
$25.6M Buy
532,937
+328,227
+160% +$15.8M 0.01% 847
2014
Q4
$6.8M Buy
204,710
+6,481
+3% +$215K ﹤0.01% 1841
2014
Q3
$5.81M Sell
198,229
-36,575
-16% -$1.07M ﹤0.01% 1930
2014
Q2
$9.12M Buy
234,804
+46,274
+25% +$1.8M 0.01% 1617
2014
Q1
$7.91M Buy
188,530
+26,992
+17% +$1.13M ﹤0.01% 1707
2013
Q4
$5.3M Buy
161,538
+123,137
+321% +$4.04M ﹤0.01% 1962
2013
Q3
$1.04M Sell
38,401
-48,599
-56% -$1.31M ﹤0.01% 2674
2013
Q2
$2.03M Buy
+87,000
New +$2.03M ﹤0.01% 2356